wegovy vs ozempic vs tirzepatide vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits Tirzepatide vs Semaglutide for Weight

Description

Compared with daily insulin glargine and degludec, once-weekly tirzepatide significantly decreased HbA1c (WMD 1.08%, 95% CI (1.37, 0.78)), 2h-posprandial blood sugar (BS) (WMD 28.19 mg/dL, 95% CI (44.98, 11.41)), pre-meal BS (WMD 11.86 mg/dL, 95% CI (22.83, 0.9)), body weight (WMD 10.61 kg, 95% CI (13.24, 7.97)), systolic blood pressure (WMD 6.47 mmHg, 95% CI (8.32, 4.61)), diastolic blood pressure (WMD 2.30 mmHg, 95% CI (3.05, 1.55)), total cholesterol (WMD 4.78%, 95% CI (7.05, 2.50)), triglyceride (WMD 14.49%, 95% CI (19.55, 9.43)), LDL cholesterol (WMD 5.98%, 95% CI (9.83, 2.13)), and VLDL cholesterol (WMD 14.18%, 95% CI (19.03, 9.33)) and increased HDL cholesterol (WMD 7.13%, 95% CI (9.83, 2.13)), with a lower risk of hypoglycemia defined as BS 70 mg/dL (RR 0.46, 95% CI (0.28, 0.75))

If you are getting started with peptides for the first time, the abdomen is usually the best place to begin because it is easy to see, easy to reach, and easy to pinch

By extending earlier preclinical work on GLP-1 receptor agonists and alcohol intake to a task that directly assesses the subjective effects of alcohol, these findings provide important context for interpreting clinical observations of reduced drinking behavior among individuals receiving GLP-1 receptor-based therapies